Cell–matrix interactions governing skin repair: matricellular proteins as diverse modulators of cell function

References

• Elliott CG, Hamilton DW. Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration? J Cell Commun Signal. 2011;5(4):301–315.
   Web of Science ®Google Scholar
• Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res. 2012;49(1):35–43.
   PubMed Web of Science ®Google Scholar
• Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 2004;36:1031–1037.
   PubMed Web of Science ®Google Scholar
• Martin [webpage on the Internet]. Wound healing – aiming for perfect skin regeneration. Science. 1997;276(5309):75–81.
   PubMed Web of Science ®Google Scholar
• Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738–746.
   PubMed Web of Science ®Google Scholar
• Hunt TK, Hopf H, Hussain Z. Physiology of wound healing. Adv Skin Wound Care. 2000;13(2 Suppl):6–11.
   PubMedGoogle Scholar
• Jeffcoate WJ, Price PE, Phillips CJ, et al. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technol Assess. 2009;13(54):1–86, iii–iv.
   PubMed Web of Science ®Google Scholar
• Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52:17S–22S.
   PubMed Web of Science ®Google Scholar
• Mustoe TA, O’Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg. 2006;117(7 Suppl):35S–41S.
   PubMed Web of Science ®Google Scholar
• Markova A, Mostow EN. US skin disease assessment: ulcer and wound care. Dermatol Clin. 2012;30(1):107–111, ix.
   PubMed Web of Science ®Google Scholar
• Woodbury M, Houghton P. Prevalence of pressure ulcers in Canadian healthcare settings. Ostomy Wound Manage. 2004;50(10):22–24, 26, 28, 30, 32, 34, 36–38.
   PubMedGoogle Scholar
• Woodbury M, Houghton P. The extent of chronic wounds in Canada. Wound Care Canada. 2005;3(1):18–52.
   Google Scholar
• Reiber GE. The epidemiology of diabetic foot problems. Diabet Med. 1996;13 Suppl 1:S6–S11.
   Google Scholar
• Gardner SE, Frantz RA. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs. 2008;10(1):44–53.
   Web of Science ®Google Scholar
• Gary Sibbald R, Woo KY. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev. 2008;24 Suppl 1:S25–S30.
   Google Scholar
• Kravitz SR, McGuire J, Zinszer K. Management of skin ulcers: understanding the mechanism and selection of enzymatic debriding agents. Adv Skin Wound Care. 2008;21:72–74.
   Google Scholar
• Wall IB, Moseley R, Baird DM, et al. Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol. 2008;128(10):2526–2540.
   PubMed Web of Science ®Google Scholar
• Zgonis T, Stapleton JJ, Girard-Powell VA, Hagino RT. Surgical management of diabetic foot infections and amputations. Aorn J. 2008;87(5):935–946; quiz 947–950.
   Google Scholar
• Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17(6):763–771.
   PubMed Web of Science ®Google Scholar
• Acosta JB, del Barco DG, Vera DC, et al. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J. 2008;5(4):530–539.
   Web of Science ®Google Scholar
• Montfrans CV, Stok M, Geerkens M. Biology of chronic wounds and new treatment strategies. Phlebology. 2014;29(1 Suppl):165–167.
   Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585–601.
   PubMed Web of Science ®Google Scholar
• Finnson KW, McLean S, Di Guglielmo GM, Philip A. Dynamics of transforming growth factor beta signaling in wound healing and scarring. Adv Wound Care. 2013;2(5):195–214.
   PubMedGoogle Scholar
• Robson MC, Mustoe TA, Hunt TK. The future of recombinant growth factors in wound healing. Am J Surg. 1998;176(2A Suppl):80S–82S.
   Web of Science ®Google Scholar
• Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol. 1995;130(3):503–506.
   Web of Science ®Google Scholar
• Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002;14(5):608–616.
   PubMed Web of Science ®Google Scholar
• Murphy-Ullrich JE, Sage EH. Revisiting the matricellular concept. Matrix Biol. 2014;37:1–14.
   PubMed Web of Science ®Google Scholar
• Basu A, Kligman LH, Samulewicz SJ, Howe CC. Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40). BMC Cell Biol. 2001;2:15.
   PubMedGoogle Scholar
• Kyriakides TR, Bornstein P. Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost. 2003;90(6):986–992.
   PubMed Web of Science ®Google Scholar
• Puolakkainen PA, Bradshaw AD, Brekken RA, et al. SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges. J Histochem Cytochem. 2005;53(5):571–581.
   Web of Science ®Google Scholar
• Hamilton DW. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal. 2008;2(1–2):9–17.
   Web of Science ®Google Scholar
• Jackson-Boeters L, Wen W, Hamilton DW. Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair. J Cell Commun Signal. 2009;3(2):125–133.
   Web of Science ®Google Scholar
• Zhou HM, Wang J, Elliott C, Wen W, Hamilton DW, Conway SJ. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J Cell Commun Signal. 2010;4(2):99–107.
   PubMed Web of Science ®Google Scholar
• Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol. 1988;107(6 Pt 2):2757–2767.
   PubMed Web of Science ®Google Scholar
• Murakami R, Yamaoka I, Sakakura T. Appearance of tenascin in healing skin of the mouse: possible involvement in seaming of wounded tissues. Int J Dev Biol. Dec 1989;33(4):439–444.
   Google Scholar
• Betz P, Nerlich A, Tubel J, Penning R, Eisenmenger W. Localization of tenascin in human skin wounds – an immunohistochemical study. Int J Legal Med. 1993;105(6):325–328.
   Web of Science ®Google Scholar
• Luomanen M, Virtanen I. Distribution of tenascin in healing incision, excision and laser wounds. J Oral Pathol Med. 1993;22(1):41–45.
   Web of Science ®Google Scholar
• Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol. 2002;22(24):8709–8720.
   PubMed Web of Science ®Google Scholar
• Ivkovic S, Yoon BS, Popoff SN, et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 2003;130(12):2779–2791.
   PubMed Web of Science ®Google Scholar
• Yang Z, Kyriakides TR, Bornstein P. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell. 2000;11(10):3353–3364.
   Web of Science ®Google Scholar
• Kyriakides TR, Rojnuckarin P, Reidy MA, et al. Megakaryocytes require thrombospondin-2 for normal platelet formation and function. Blood. 2003;101(10):3915–3923.
   Web of Science ®Google Scholar
• Elliott CG, Wang J, Guo X, et al. Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J Cell Sci. 2012;125(Pt 1):121–132.
   Web of Science ®Google Scholar
• Liu S, Thompson K, Leask A. CCN2 expression by fibroblasts is not required for cutaneous tissue repair. Wound Repair Regen. 2014;22(1):119–124.
   Web of Science ®Google Scholar
• Tsang M, Leask A. CCN2 is required for recruitment of Sox2-expressing cells during cutaneous tissue repair. J Cell Commun Signal. Epub October 18, 2014.
   Google Scholar
• Dorsett-Martin WA, Wysocki A.. Rat models of skin wound healing. In: Conn PM, editor. Sourcebook of Models for Biomedical Research. Totowa, NJ: Springer; 2008:631–638.
   Google Scholar
• Greiling D, Clark RA. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci. 1997;110(Pt 7):861–870.
   PubMedGoogle Scholar
• DiPietro LA. Wound healing: the role of the macrophage and other immune cells. Shock. 1995;4(4):233–240.
   PubMed Web of Science ®Google Scholar
• Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol. 1975;78(1):71–100.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13:453–461.
   PubMed Web of Science ®Google Scholar
• Mills CD. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol. 2012;32(6):463–488.
   PubMed Web of Science ®Google Scholar
• Jaguin M, Houlbert N, Fardel O, Lecureur V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell Immunol. 2013;281(1):51–61.
   PubMed Web of Science ®Google Scholar
• Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A. 1987;84(17):6020–6024.
   Web of Science ®Google Scholar
• Morikawa S, Ezaki T. Phenotypic changes and possible angiogenic roles of pericytes during wound healing in the mouse skin. Histol Histopathol. 2011;26(8):979–995.
   Web of Science ®Google Scholar
• Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003;200(4):500–503.
   PubMed Web of Science ®Google Scholar
• Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen. 2005;13(1):7–12.
   PubMed Web of Science ®Google Scholar
• Kyriakides TR, Zhu YH, Smith LT, et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol. 1998;140(2):419–430.
   Web of Science ®Google Scholar
• Liu FT, Hsu DK. The role of galectin-3 in promotion of the inflammatory response. Drug News Perspect. 2007;20(7):455–460.
   PubMedGoogle Scholar
• Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol. 1998;152(2):353–358.
   PubMed Web of Science ®Google Scholar
• Miragliotta V, Pirone A, Donadio E, Abramo F, Ricciardi MP, Theoret CL. Osteopontin expression in healing wounds of horses and in human keloids. Equine Vet J. Epub October 7, 2014.
   Google Scholar
• Mori R, Shaw TJ, Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med. 2008;205(1):43–51.
   Web of Science ®Google Scholar
• Sullivan MM, Puolakkainen PA, Barker TH, Funk SE, Sage EH. Altered tissue repair in hevin-null mice: inhibition of fibroblast migration by a matricellular SPARC homolog. Wound Repair Regen. 2008;16(2):310–319.
   Web of Science ®Google Scholar
• Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol. 2002;161(3):831–839.
   Web of Science ®Google Scholar
• Rabinovich GA, Baum LG, Tinari N, et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 2002;23(6):313–320.
   PubMed Web of Science ®Google Scholar
• MacKinnon AC, Farnworth SL, Hodkinson PS, et al. Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008;180(4):2650–2658.
   PubMed Web of Science ®Google Scholar
• Juniantito V, Izawa T, Yamamoto E, Murai F, Kuwamura M, Yamate J. Heterogeneity of macrophage populations and expression of galectin-3 in cutaneous wound healing in rats. J Comp Pathol. 2011;145(4):378–389.
   Web of Science ®Google Scholar
• Bhaumik P, St-Pierre G, Milot V, St-Pierre C, Sato S. Galectin-3 facilitates neutrophil recruitment as an innate immune response to a parasitic protozoa cutaneous infection. J Immunol. 2013;190(2):630–640.
   Web of Science ®Google Scholar
• Verrecchia F, Pessah M, Atfi A, Mauviel A. Tumor necrosis factor-α inhibits transforming growth factor-β/Smad signaling in human dermal fibroblasts via AP-1 activation. J Biol Chem. 2000;275(39):30226–30231.
   Web of Science ®Google Scholar
• Goldberg M, Han Y, Yan C, Shaw M. TNF-α suppresses α-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol. 2007;127(11):2645–2655.
   PubMed Web of Science ®Google Scholar
• Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen. 1996;4(3):321–325.
   PubMedGoogle Scholar
• Nomiyama T, Perez-Tilve D, Ogawa D, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest. 2007;117(10):2877–2888.
   PubMed Web of Science ®Google Scholar
• Uaesoontrachoon K, Wasgewatte Wijesinghe DK, Mackie EJ, Pagel CN. Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injury. Dis Model Mech. 2013;6(1):197–205.
   Web of Science ®Google Scholar
• Li XD, Chen J, Ruan CC, Zhu DL, Gao PJ. Vascular endothelial growth factor-induced osteopontin expression mediates vascular inflammation and neointima formation via Flt-1 in adventitial fibroblasts. Arterioscler Thromb Vasc Biol. 2012;32(9):2250–2258.
   Web of Science ®Google Scholar
• Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest. 1998;101(7):1468–1478.
   PubMed Web of Science ®Google Scholar
• Madsen DH, Leonard D, Masedunskas A, et al. M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway. J Cell Biol. 2013;202(6):951–966.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.
   PubMedGoogle Scholar
• DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ. Thrombospondin 1 synthesis and function in wound repair. Am J Pathol. 1996;148(6):1851–1860.
   Web of Science ®Google Scholar
• Velasco P, Huegel R, Brasch J, et al. The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions. J Invest Dermatol. 2009;129(8):2022–2030.
   Web of Science ®Google Scholar
• Halper J, Kjaer M. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv Exp Med Biol. 2014;802:31–47.
   PubMed Web of Science ®Google Scholar
• Forsberg E, Hirsch E, Frohlich L, et al. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci U S A. 1996;93(13):6594–6599.
   PubMed Web of Science ®Google Scholar
• Egging D, van Vlijmen-Willems I, van Tongeren T, Schalkwijk J, Peeters A. Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition. Connect Tissue Res. 2007;48(2):93–98.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Saga Y, Ikemura T, Sakakura T, Chiquet-Ehrismann R. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J Cell Biol. 1994;125(2):483–493.
   Web of Science ®Google Scholar
• Bradshaw AD, Reed MJ, Sage EH. SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem. 2002;50(1):1–10.
   PubMed Web of Science ®Google Scholar
• Elliott CG, Kim SS, Hamilton DW. Functional significance of periostin in excisional skin repair: is the devil in the detail? Cell Adh Migr. 2012;6(4):319–326.
   PubMed Web of Science ®Google Scholar
• Murphy-Ullrich JE. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest. 2001;107(7):785–790.
   PubMed Web of Science ®Google Scholar
• Sullivan MM, Barker TH, Funk SE, et al. Matricellular hevin regulates decorin production and collagen assembly. J Biol Chem. 2006;281(37):27621–27632.
   PubMed Web of Science ®Google Scholar
• Kyriakides TR, Tam JW, Bornstein P. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol. 1999;113(5):782–787.
   Web of Science ®Google Scholar
• Kapoor M, Liu S, Huh K, Parapuram S, Kennedy L, Leask A. Connective tissue growth factor promoter activity in normal and wounded skin. Fibrogenesis Tissue Repair. 2008;1(1):3.
   PubMedGoogle Scholar
• Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 1993;4(6):637–645.
   PubMed Web of Science ®Google Scholar
• Ontsuka K, Kotobuki Y, Shiraishi H, et al. Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts. Exp Dermatol. 2012;21(5):331–336.
   PubMed Web of Science ®Google Scholar
• Perbal B. CCN proteins: a centralized communication network. J Cell Commun Signal. 2013;7(3):169–177.
   Web of Science ®Google Scholar
• Liu S, Shi-wen X, Abraham DJ, Leask A. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum. 2011;63(1):239–246.
   PubMed Web of Science ®Google Scholar
• Liu S, Shi-Wen X, Abraham DJ, Leask A. CCN2 is required for bleomycin-induced skin fibrosis. Arthritis Rheum. Epub October 8, 2010.
   Google Scholar
• Kennedy L, Liu S, Shi-Wen X, et al. CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res. 2007;313(5):952–964.
   Web of Science ®Google Scholar
• Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008;19(2):133–144.
   PubMed Web of Science ®Google Scholar
• Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM, Lau LF. Integrin-dependent functions of the angiogenic inducer NOV (CCN3):implication in wound healing. J Biol Chem. 2005;280(9):8229–8237.
   Web of Science ®Google Scholar
• Pastar I, Stojadinovic O, Yin NC, et al. Epithelialization in wound healing: a comprehensive review. Adv Wound Care. 2014;3(7):445–464.
   PubMedGoogle Scholar
• Aukhil I, Sahlberg C, Thesleff I. Basal layer of epithelium expresses tenascin mRNA during healing of incisional skin wounds. J Periodontal Res. 1996;31(2):105–112.
   Web of Science ®Google Scholar
• Cao Z, Said N, Amin S, et al. Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds. J Biol Chem. 2002;277(44):42299–42305.
   PubMed Web of Science ®Google Scholar
• Liu W, Hsu DK, Chen HY, et al. Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migration. J Invest Dermatol. 2012;132(12):2828–2837.
   PubMed Web of Science ®Google Scholar
• Klima J, Lacina L, Dvorankova B, et al. Differential regulation of galectin expression/reactivity during wound healing in porcine skin and in cultures of epidermal cells with functional impact on migration. Physiol Res. 2009;58(6):873–884.
   Web of Science ®Google Scholar
• Nishiyama T, Kii I, Kashima TG, et al. Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing. PLoS One. 2011;6(4):e18410.
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol. 2003;81(6):355–363.
   PubMed Web of Science ®Google Scholar
• Wong VW, Sorkin M, Glotzbach JP, Longaker MT, Gurtner GC. Surgical approaches to create murine models of human wound healing. J Biomed Biotechnol. 2011;2011:969618.
   PubMedGoogle Scholar
• Roth JJ, Hughes WB, DeClement FA, Hensell DO, Granick MS, Tuszynski GP. The 1998 Moyer Award. Characteristics of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in burn wounds. J Burn Care Rehabil. 1998;19(6):487–493.
   Google Scholar
• Roth JJ, Albo D, Rothman VL, et al. Thrombospondin-1 and its CSVTCG-specific receptor in wound healing and cancer. Ann Plast Surg. 1998;40(5):494–501.
   Web of Science ®Google Scholar
• Latijnhouwers MA, Bergers M, Van Bergen BH, Spruijt KI, Andriessen MP, Schalkwijk J. Tenascin expression during wound healing in human skin. J Pathol. 1996;178(1):30–35.
   Web of Science ®Google Scholar
• Latijnhouwers M, Bergers M, Ponec M, Dijkman H, Andriessen M, Schalkwijk J. Human epidermal keratinocytes are a source of tenascin-C during wound healing. J Invest Dermatol. 1997;108(5):776–783.
   Web of Science ®Google Scholar
• Rittie L, Perbal B, Castellot JJ Jr, Orringer JS, Voorhees JJ, Fisher GJ. Spatial-temporal modulation of CCN proteins during wound healing in human skin in vivo. J Cell Commun Signal. 2011;5(1):69–80.
   Web of Science ®Google Scholar
• Metcalfe AD, Ferguson MW. Bioengineering skin using mechanisms of regeneration and repair. Biomaterials. 2007;28(34):5100–5113.
   PubMed Web of Science ®Google Scholar
• Black E, Vibe-Petersen J, Jorgensen LN, et al. Decrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic control. Arch Surg. 2003;138(1):34–40.
   Google Scholar
• Thackham JA, McElwain DL, Long RJ. The use of hyperbaric oxygen therapy to treat chronic wounds: a review. Wound Repair Regen. 2008;16(3):321–330.
   PubMed Web of Science ®Google Scholar
• Tsourdi E, Barthel A, Rietzsch H, Reichel A, Bornstein SR. Current aspects in the pathophysiology and treatment of chronic wounds in diabetes mellitus. Biomed Res Int. 2013;2013:385641.
   PubMed Web of Science ®Google Scholar
• Bucalo B, Eaglstein WH, Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen. 1993;1(3):181–186.
   Google Scholar
• Wallace HJ, Stacey MC. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers – correlations to healing status. J Invest Dermatol. 1998;110(3):292–296.
   PubMed Web of Science ®Google Scholar
• Pepe D, Elliott CG, Forbes T, Hamilton DW. Detection of galectin-3 and localization of advanced glycation end products (AGE) in human chronic skin wounds. Histol Histopathol. 2014;29(2):251–258.
   PubMed Web of Science ®Google Scholar
• Zhu W, Sano H, Nagai R, Fukuhara K, Miyazaki A, Horiuchi S. The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins. Biochem Biophys Res Commun. 2001;280(4):1183–1188.
   Web of Science ®Google Scholar
• Raffetto JD. Inflammation in chronic venous ulcers. Phlebology. 2013;28 Suppl 1:61–67.
   Google Scholar
• Oberyszyn TM. Inflammation and wound healing. Front Biosci. 2007;12:2993–2999.
   Web of Science ®Google Scholar
• Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9:283–289.
   PubMed Web of Science ®Google Scholar
• Crawford J, Nygard K, Gan BS, O’Gorman DB. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring. Exp Dermatol. Epub November 24, 2014.
   Google Scholar
• Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol. 2012;26(2):141–152.
   PubMed Web of Science ®Google Scholar
• Streit M, Velasco P, Riccardi L, et al. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J. 2000;19(13):3272–3282.
   PubMed Web of Science ®Google Scholar
• Bornstein P, Agah A, Kyriakides TR. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol. 2004;36(6):1115–1125.
   Web of Science ®Google Scholar
• Agah A, Kyriakides TR, Letrondo N, Björkblom B, Bornstein P. Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis. Matrix Biol. 2004;22(7):539–547.
   Web of Science ®Google Scholar
• Maclauchlan S, Skokos EA, Agah A, et al. Enhanced Angiogenesis and Reduced Contraction in Thrombospondin-2–null Wounds Is Associated With Increased Levels of Matrix Metalloproteinases-2 and -9, and Soluble VEGF. J Histochem Cytochem. 2009;57(4):301–313.
   Web of Science ®Google Scholar
• Gendronneau G, Sidhu SS, Delacour D, et al. Galectin-7 in the Control of Epidermal Homeostasis after Injury. Mol Biol Cell. 2008;19(12):5541–5549.
   PubMed Web of Science ®Google Scholar
• Brinckmann J, Hunzelmann N, Kahle B, et al. Enhanced fibrillin-2 expression is a general feature of wound healing and sclerosis: potential alteration of cell attachment and storage of TGF-beta. Lab Invest. 2010;90(5):739–752.
   PubMed Web of Science ®Google Scholar